Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Atorvastatin (Primary)
- Indications Chemotherapy-induced damage; Heart disorders
- Focus Therapeutic Use
- Acronyms PREVENT
- 17 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 17 Apr 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2017.
- 24 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.